Filing Details

Accession Number:
0000921895-21-000687
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-09 17:06:12
Reporting Period:
2021-03-05
Accepted Time:
2021-03-09 17:06:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Plx Pharma Inc. PLXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1319551 J Michael Valentino 9 Fishers Lane
Suite E
Sparta NJ 07871
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-05 25,000 $8.00 486,690 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's underwritten public offering of common stock, which closed on March 5, 2021.